Reply To: Traders Market Weekly: NVidia, AI and The Debt Celling

15 May '23 at 8:02 am #58619
Truman
Participant

Sarepta Therapeutics (SRPT 154.52, +34.32, +28.6%): receives Positive Vote from FDA Advisory Committee Meeting for SRP-9001 gene therapy to treat duchenne muscular dystrophy